Boston Cell Standards: For Prodct, it’s personal.
ABOUT BOSTON CELL STANDARDS
Boston Cell Standards is the first and only company to develop and manufacture standardized reference materials in the immunohistochemistry (IHC) industry. Its mission is to improve patient outcomes by ensuring that immunohistochemistry test results are accurate and reproducible regardless of where or when tests are performed. Laboratory reference materials are essential for that purpose. The company brings together outstanding physicians, scientists, and staff in a creative and supportive environment with the goal of spurring groundbreaking advances that can be applied to the laboratory setting.
Late 2022, Boston Cell Standards announced it received 510(k) clearance from the U.S. Food & Drug Administration for its IHControls® panel (HER2/ER/PR) for evaluating breast cancers.
This clearance represents a first-in-category regulatory approval.
IHControls are the first truly quantitative linear range controls for IHC labs. This panel provides anatomic pathologists a reproducible, cost-effective solution for on-slide quality control, to safeguard against the potential for incorrect results and increase physician confidence in making diagnoses and selecting treatments
FOR PRODCT, IT’S PERSONAL
BCS technology will revolutionize IHC cancer diagnoses - the immense impact of which was intoxicating for us at Prodct. How could we NOT answer the call when BCS reached out to us!?
What we didn’t expect was the depth of the relationships we’ve fostered at BCS. When was the last time you invited your out-of-town advisors to stay in your home and share a bottle of wine when they visit for QMS and risk management training? Probably, never. For Prodct and BCS, that’s every visit! We love this team and are supremely appreciative of our opportunity to become part of the BCS family.
We laugh together, we share meals together in each other's homes – and we build amazing products while implementing robust, scalable business processes. Win-win
